Search filters

List of works by Tamás Masszi

A phase 2, randomized, double-blind, placebo-controlled study of siltuximab (anti-IL-6 mAb) and bortezomib versus bortezomib alone in patients with relapsed or refractory multiple myeloma.

scientific article

A randomized phase III study of carfilzomib vs low-dose corticosteroids with optional cyclophosphamide in relapsed and refractory multiple myeloma (FOCUS).

scientific article

Accelerated clearance alone explains ultra-large multimers in von Willebrand disease Vicenza

scientific article published on 17 January 2010

Additional chromosome abnormalities, BCR-ABL tyrosine kinase domain mutations and clinical outcome in Hungarian tyrosine kinase inhibitor-resistant chronic myelogenous leukemia patients

scientific article published on 14 October 2011

Allogeneic bone marrow transplantation for acute leukaemia--IGCI experience. International Group for Chemo-Immunotherapy.

scientific article

Allogeneic bone marrow transplantation for acute leukemia in adults

scientific article published on 01 December 1998

Allogeneic hematopoietic stem-cell transplantation for acute myeloid leukemia in remission: comparison of intravenous busulfan plus cyclophosphamide (Cy) versus total-body irradiation plus Cy as conditioning regimen--a report from the acute leukemia

scientific article published on 26 August 2013

An Alu-mediated novel large deletion is the most frequent cause of type 3 von Willebrand disease in Hungary

article

Analyses of Donor-Derived Keratinocytes in Hairy and Nonhairy Skin Biopsies of Female Patients Following Allogeneic Male Bone Marrow Transplantation ⬇️

scientific article published on March 17, 2011

Analysis of platelet alpha2-adrenergic receptor activity in stable coronary artery disease patients on dual antiplatelet therapy

scientific article published on 01 November 2008

Anti-thymocyte globulin improves survival free from relapse and graft-versus-host disease after allogeneic peripheral blood stem cell transplantation in patients with Philadelphia-negative acute lymphoblastic leukemia: An analysis by the Acute Leuke

scientific article published on 30 March 2018

Apoptosis induction by retinoids in eosinophilic leukemia cells: implication of retinoic acid receptor-alpha signaling in all-trans-retinoic acid hypersensitivity.

scientific article published on June 2006

Autologous stem cell transplantation for malignant lymphomas

scientific article published on 01 December 1998

Belinostat in Patients With Relapsed or Refractory Peripheral T-Cell Lymphoma: Results of the Pivotal Phase II BELIEF (CLN-19) Study.

scientific article

Bone marrow transplantation in non-malignant disorders

scientific article published on 01 December 1998

Bortezomib, thalidomide and dexamethasone, with or without cyclophosphamide, for patients with previously untreated multiple myeloma: 5-year follow-up.

scientific article published on 7 July 2015

Bosutinib efficacy and safety in chronic phase chronic myeloid leukemia after imatinib resistance or intolerance: Minimum 24-month follow-up

scientific article

Brentuximab vedotin as consolidation therapy after autologous stem-cell transplantation in patients with Hodgkin's lymphoma at risk of relapse or progression (AETHERA): a randomised, double-blind, placebo-controlled, phase 3 trial.

scientific article published on 19 March 2015

CIDP cured by allogeneic hematopoietic stem cell transplantation

scientific article published on 01 August 2007

Carfilzomib significantly improves the progression-free survival of high-risk patients in multiple myeloma.

scientific article published on 20 July 2016

Carfilzomib, lenalidomide, and dexamethasone in patients with relapsed multiple myeloma categorised by age: secondary analysis from the phase 3 ASPIRE study

scientific article

Carfilzomib-lenalidomide-dexamethasone vs lenalidomide-dexamethasone in relapsed multiple myeloma by previous treatment

scientific article

Changes in quality of life and disease-related symptoms in patients with polycythemia vera receiving ruxolitinib or standard therapy

scientific article published on 26 November 2015

Characterization and function of histamine receptors in human bone marrow stromal cells.

scientific article

Characterization of ABL exon 7 deletion by molecular genetic and bioinformatic methods reveals no association with imatinib resistance in chronic myeloid leukemia.

scientific article

Chronic lymphoid leukemia cells are highly sensitive to the combination of prednisolone and daunorubicin, but much less to doxorubicin or epirubicin.

scientific article

Co-occurrence of Myeloproliferative Neoplasms and Solid Tumors Is Attributed to a Synergism Between Cytoreductive Therapy and the Common TERT Polymorphism rs2736100.

scientific article published on 20 October 2015

Common large partial VWF gene deletion does not cause alloantibody formation in the Hungarian type 3 von Willebrand disease population

scientific article published on 01 May 2011

Comparable results of autologous and allogeneic haematopoietic stem cell transplantation for adults with Philadelphia-positive acute lymphoblastic leukaemia in first complete molecular remission: An analysis by the Acute Leukemia Working Party of th

scientific article published on 18 April 2018

Comprehensive haematological control with ruxolitinib in patients with polycythaemia vera resistant to or intolerant of hydroxycarbamide.

scientific article

Daratumumab, Bortezomib, and Dexamethasone for Multiple Myeloma

scientific article

Dasatinib in imatinib-resistant or imatinib-intolerant chronic myeloid leukemia in blast phase after 2 years of follow-up in a phase 3 study: efficacy and tolerability of 140 milligrams once daily and 70 milligrams twice daily

scientific article published on August 2010

Dasatinib or high-dose imatinib for chronic-phase chronic myeloid leukemia after failure of first-line imatinib: a randomized phase 2 trial.

scientific article

Diffusion weighted magnetic resonance imaging demonstrates tumor response following palliative embolization of a recurrent shoulder plasmacytoma

scientific article published on 22 August 2014

Distinct clinical characteristics of myeloproliferative neoplasms with calreticulin mutations.

scientific article

Donor KIR2DS1 reduces the risk of transplant related mortality in HLA-C2 positive young recipients with hematological malignancies treated by myeloablative conditioning

scientific article published on 25 June 2019

Drugs, gene transfer, signaling factors: a bench to bedside approach to myocardial stem cell therapy.

scientific article published on August 2007

Durable treatment-free remission in patients with chronic myeloid leukemia in chronic phase following frontline nilotinib: 96-week update of the ENESTfreedom study

scientific article published on 22 February 2018

Early Versus Delayed Autologous Stem Cell Transplantation and Interferon Maintenance in Multiple Myeloma: Single-Center Experience of 18 Years.

scientific article

Efficacy and Tolerability of a 2-Year Rituximab Maintenance Therapy in Patients with Advanced Follicular Lymphoma after Induction of Response with Rituximab-Containing First Line-Regimens (HUSOM Study).

scientific article published on 21 April 2017

Efficacy and safety of ruxolitinib after and versus interferon use in the RESPONSE studies

scientific article published on 2 February 2018

Expanding Nilotinib Access in Clinical Trials (ENACT), an open-label multicenter study of oral nilotinib in adult patients with imatinib-resistant or -intolerant chronic myeloid leukemia in accelerated phase or blast crisis.

scientific article published on 5 December 2011

Five-year PFS from the AETHERA trial of brentuximab vedotin for Hodgkin lymphoma at high risk of progression or relapse.

scientific article

Frontline nilotinib in patients with chronic myeloid leukemia in chronic phase: results from the European ENEST1st study.

scientific article

HFE C282Y mutation as a genetic modifier influencing disease susceptibility for chronic myeloproliferative disease.

scientific article published on 3 March 2009

Haematopoietic stem cell mobilization with plerixafor and G-CSF in patients with multiple myeloma transplanted with autologous stem cells

scientific article published on 01 April 2011

Haematopoietic stem cell transplantation in children in eastern European countries 1985-2004: development, recent activity and role of the EBMT/ESH Outreach Programme

scientific article published on 01 June 2008

Health-Related Quality of Life Results From the Open-Label, Randomized, Phase III ASPIRE Trial Evaluating Carfilzomib, Lenalidomide, and Dexamethasone Versus Lenalidomide and Dexamethasone in Patients With Relapsed Multiple Myeloma.

scientific article published on 6 September 2016

Health-related quality of life of bosutinib (SKI-606) in imatinib-resistant or imatinib-intolerant chronic phase chronic myeloid leukemia

scientific article published on 28 October 2011

High dose chemotherapy and autologous stem cell transplantation in nodular lymphocyte-predominant Hodgkin lymphoma: A retrospective study by the European society for blood and marrow transplantation-lymphoma working party

scientific article published on 3 October 2017

Identification of prognostic factors for plerixafor-based hematopoietic stem cell mobilization.

scientific article published on 14 June 2011

Impact of extramedullary disease in patients with newly diagnosed multiple myeloma undergoing autologous stem cell transplantation: A study from the Chronic Malignancies Working Party of the EBMT.

scientific article

Impact of prior therapy on the efficacy and safety of oral ixazomib-lenalidomide-dexamethasone vs. placebo-lenalidomide-dexamethasone in patients with relapsed/refractory multiple myeloma in TOURMALINE-MM1.

scientific article

Invasive fungal disease in allogeneic hematopoietic stem cell transplant recipients: an autopsy-driven survey

scientific article

Ixazomib significantly prolongs progression-free survival in high-risk relapsed/refractory myeloma patients.

scientific article published on 20 October 2017

JAK2 46/1 haplotype analysis in myeloproliferative neoplasms and acute myeloid leukemia.

scientific article

Lack of correlation between the number of donor nucleated bone marrow cells or CFU-GM content and the rapidity of engraftment in allogeneic BMT

scientific article published on 01 January 1993

Late cardiovascular events after allogeneic hematopoietic stem cell transplantation: a retrospective multicenter study of the Late Effects Working Party of the European Group for Blood and Marrow Transplantation

scientific article published on 12 June 2008

Lipoprotein Lipase as a Prognostic Marker in Chronic Lymphocytic Leukemia.

scientific article

Lymphocyte subset reconstitution after allogeneic bone marrow transplantation using radiation-free conditioning regimen for patients with chronic granulocytic leukemia

scientific article published on 01 July 1995

Lymphoid aggregates may contribute to the migration and epithelial commitment of bone marrow-derived cells in colonic mucosa.

scientific article published on 8 June 2011

Management of adverse events associated with ixazomib plus lenalidomide/dexamethasone in relapsed/refractory multiple myeloma

scientific article

Medium-sized FLT3 internal tandem duplications confer worse prognosis than short and long duplications in a non-elderly acute myeloid leukemia cohort.

scientific article published on 25 November 2013

Molecular background of a new case of chronic myelogenous leukemia with bcr-abl chimera mRNA lacking the A2 exon

scientific article published on 01 October 1994

Multiple Myeloma of the Central Nervous System: 13 Cases and Review of the Literature.

scientific article

NFKB1 -94ins/delATTG polymorphism is a novel prognostic marker in first line-treated multiple myeloma

scientific article published on 03 November 2014

Outcome of HLA-matched related allogeneic hematopoietic stem cell transplantation for patients with acute leukemia in first complete remission treated in Eastern European centers. Better results in recent years

scientific article published on 20 March 2009

Patient-reported health-related quality of life from the phase III TOURMALINE-MM1 study of ixazomib-lenalidomide-dexamethasone versus placebo-lenalidomide-dexamethasone in relapsed/refractory multiple myeloma

scientific article published on 04 May 2018

Peripheral blood stem cell mobilization and engraftment after autologous stem cell transplantation with biosimilar rhG-CSF.

scientific article published in April 2014

Persistent long-term human herpesvirus 6 (HHV-6) infection in a patient with langerhans cell histiocytosis.

scientific article

Phase III open-label randomized study of cytarabine in combination with amonafide L-malate or daunorubicin as induction therapy for patients with secondary acute myeloid leukemia

scientific article published on 2 March 2015

Plerixafor for PBSC mobilisation in myeloma patients with advanced renal failure: safety and efficacy data in a series of 21 patients from Europe and the USA ⬇️

scientific article published on February 28, 2011

Plerixafor to rescue failing chemotherapy-based stem cell mobilization: it's not too late.

scientific article published on 12 June 2011

Prognostic factors in light chain amyloidosis

scientific article published on September 2015

Proteasome Subunit Beta Type 1 P11A Polymorphism Is a New Prognostic Marker in Multiple Myeloma.

scientific article published on 30 June 2017

Quality of life and its socio-demographic and psychological determinants after bone marrow transplantation.

scientific article

Quality of life results from a phase 3 study of brentuximab vedotin consolidation following autologous haematopoietic stem cell transplant for persons with Hodgkin lymphoma

scientific article published on 21 September 2016

Quantitative assessment of JAK2 V617F and CALR mutations in Philadelphia negative myeloproliferative neoplasms

scientific article

Radioguided lymph node biopsy of a chemoresistant lymph node detected on interim FDG PET-CT in Hodgkin lymphoma

scientific article published in March 2011

Randomized phase II study of bortezomib, thalidomide, and dexamethasone with or without cyclophosphamide as induction therapy in previously untreated multiple myeloma

scientific article published on 22 October 2012

Recipient and donor JAK2 46/1 haplotypes are associated with acute graft-versus-host disease following allogeneic hematopoietic stem cell transplantation.

scientific article

Reduction in the frequency of transplant-related complications in patients with chronic myeloid leukemia undergoing BMT preconditioned with a new, non-myeloablative drug combination

scientific article published on 01 April 1998

Retrospective survey on the prevalence and outcome of prior autoimmune diseases in patients with aplastic anemia reported to the registry of the European group for blood and marrow transplantation

scientific article published on 6 July 2010

Revised diagnosis and severity criteria for sinusoidal obstruction syndrome/veno-occlusive disease in adult patients: a new classification from the European Society for Blood and Marrow Transplantation.

scientific article published on 16 May 2016

Ruxolitinib versus best available therapy in patients with polycythemia vera: 80-week follow-up from the RESPONSE trial.

scientific article published on 21 April 2016

Ruxolitinib versus standard therapy for the treatment of polycythemia vera.

scientific article

Secondary ALK negative anaplastic large cell lymphoma in a patient with lymphomatoid papulosis of 40 years duration.

scientific article published in October 2010

Serum beta2-microglobulin measured by immunonephelometry: expression patterns and reference intervals in healthy adults.

scientific article published in January 2009

Sex-specific survival difference in association with HLA-DRB1∗04 following allogeneic haematopoietic stem cell transplantation for lymphoid malignancies.

scientific article

Sinusoidal obstruction syndrome/veno-occlusive disease: current situation and perspectives-a position statement from the European Society for Blood and Marrow Transplantation (EBMT)

scientific article

Skin-homing CD8 T cells preferentially express GPI-anchored peptidase inhibitor 16, an inhibitor of cathepsin K

scientific article published on 09 November 2018

Stem cell transplantation in the imatinib era

scientific article published in May 2005

Successful combined antifungal salvage therapy with liposomal amphothericin B and caspofungin for invasive Aspergillus flavus infection in a child following allogeneic bone marrow transplantation

scientific article published on 01 January 2006

Successful treatment of renal failure caused by multiple myeloma with HLA-identical living kidney and bone marrow transplantation: a case report.

scientific article published in January 2013

Superiority of the triple combination of bortezomib-thalidomide-dexamethasone over the dual combination of thalidomide-dexamethasone in patients with multiple myeloma progressing or relapsing after autologous transplantation: the MMVAR/IFM 2005-04 R

scientific article

Syngeneic transplantation in multiple myeloma - a case-matched comparison with autologous and allogeneic transplantation. European Group for Blood and Marrow Transplantation

scientific article published on 01 October 1999

Ten-Year Remission of Psoriasis after Allogeneic but Not Autologous Bone Marrow Transplantation

scientific article published on 01 January 2006

The adverse effect of FOPNL genomic variant is reversed by bortezomib-based treatment protocols in multiple myeloma

scientific article

The potential role of HLA-DRB1*11 in the development and outcome of haematopoietic stem cell transplantation-associated thrombotic microangiopathy

scientific article

The prognostic impact of germline 46/1 haplotype of Janus kinase 2 in cytogenetically normal acute myeloid leukemia.

scientific article published on 26 July 2011

Treatment-free remission following frontline nilotinib in patients with chronic myeloid leukemia in chronic phase: results from the ENESTfreedom study

scientific article

VMP (Bortezomib, Melphalan, and Prednisone) is active and well tolerated in newly diagnosed patients with multiple myeloma with moderately impaired renal function, and results in reversal of renal impairment: cohort analysis of the phase III VISTA s

scientific article

[A new radiation-free conditioning in bone marrow transplantation and dibromo-mannitol therapy in chronic myeloid leukemia]

scientific article

[Appearing of bone marrow derived stem cells in healthy and regenerating colonic epithelium].

scientific article

[Chronic myelogenous leukemia: diagnosis and treatment].

scientific article

[Complex molecular genetic algorithm in the diagnosis of myeloproliferative neoplasms].

scientific article published in December 2014

[Experiences with the first, Hungarian autologous bone marrow cell transplantation in acute myocardial infarction]

scientific article published on 01 January 2006

[Gram-negative bacteremia in neutropenic patients with hematologic disorders. Experiences with prophylactic use of fluoroquinolones]

scientific article published on 01 July 2011

[How long does a myeloma patient currently wait for the diagnosis in Hungary?]

scientific article published on 01 September 2014

[Rare case of a pregnancy in a woman with paroxysmal nocturnal hemoglobinuria. Case report]

scientific article published on 01 June 2016

[Role of the activating mutation Val617Phe of Janus kinase 2 gene in myeloproliferative diseases and significance of its detection]

scientific article published on 01 February 2007

[Stem cell therapy in cardiovascular diseases]

scientific article published on 01 November 2005

[The bone-marrow transplantation program in Hungary: report from the period 1990-1995]

scientific article published on 01 October 1996

Paulina is supported by:

About Paulina

Help